$PRME SEC Filings

Filed On	Filing
06 Aug 2026	10-Q
06 Aug 2026	8-K: Results of Operations and Financial Condition
08 Jul 2026	8-K: Other Events
08 Jun 2026	Form 4: Schenkein David P, Director Granted 75,000 Stock Option (right to buy)
08 Jun 2026	Form 4: Marrazzo Jeffrey D, Director Granted 75,000 Stock Option (right to buy)
08 Jun 2026	Form 4: Nelsen Robert, Director Granted 75,000 Stock Option (right to buy)
08 Jun 2026	Form 4: Kelly Michael Aaron, Director Granted 75,000 Stock Option (right to buy)
08 Jun 2026	Form 4: Foster-Cheek Kaye I, Director Granted 75,000 Stock Option (right to buy)
08 Jun 2026	Form 4: Chung Wendy, Director Granted 75,000 Stock Option (right to buy)
08 Jun 2026	Form 4: Cahill Thomas, Director Granted 75,000 Stock Option (right to buy)
08 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
07 May 2026	10-Q
07 May 2026	8-K: Results of Operations and Financial Condition
23 Apr 2026	ARS
23 Apr 2026	DEFA14A
23 Apr 2026	Proxy statement: annual meeting on June 5, 2026
17 Apr 2026	Form 4: Makhni Svetlana Ni, Chief Financial Officer Granted 800,000 Stock Option (right to buy)
17 Apr 2026	Form 3: Makhni Svetlana Ni, Chief Financial Officer No securities owned
16 Apr 2026	8-K: Departure/Election of Directors or Officers; Compensation
04 Mar 2026	EFFECT

Comments